Granulés de 6-APB 130 mg
Granulés de 6-APB 130 mg Gamme de prix : €5.95 à €737.50
Retour aux produits
1V-LSD Valérie 225mcg
1V-LSD Valérie 225mcg Gamme de prix : €10.00 à €369.00

aMT

aMT properties

Synonyme: alpha-méthyltryptamine
Numéro CAS : 299-26-3
Formule: C11H14N2
Masse molaire: 174.247 g mol−1
Pureté: >98%

Gamme de prix : €34.95 à €499.95

* Les informations présentées sur cette page constituent un résumé et ne couvrent pas toutes les informations disponibles sur ce médicament. Elles ne couvrent pas toutes les utilisations, posologies, précautions, interactions médicamenteuses ni les effets indésirables possibles, et ne sauraient se substituer à l'expertise et au jugement de votre professionnel de la santé.

AMT (Alpha-Methyltryptamine) – Scientific Product Description

General Information

Substance Name:  Alpha-Methyltryptamine (AMT)
Chemical Class:  Tryptamine derivative
Statut:  Research chemical
Dosage:  Varies (10-50mg for research purposes)
Form:  Powder or pellets (depending on availability)

Propriétés pharmacologiques

AMT is a monoamine alkaloid with a unique mechanism of action that both:

  • Serotonergic  (5-HT₂A agonism)

  • Dopaminergic  (dopamine reuptake inhibition)

  • Exhibits noradrenergic  effects

Potential Research Areas

1. Neuropsychological Examination

  • Influence on perceptual processing

  • Modulation of cognitive flexibility

  • Effects on creative thinking

2. Behavioral Science Studies

  • Social interaction patterns

  • Emotional processing mechanisms

  • Motivation and reward systems

3. Theoretical Applications

  • Possible antidepressant effects (preclinical study)

  • Impact on sleep architecture

  • Neuroplastic changes

Dosage & Protocol

Research dose range:

  • Faible dose :  10-20mg

  • Dose moyenne :  20-35mg

  • Forte dose :  35-50mg

Time lapse:

  • Onset of effects: 45-90 minutes

  • Peak performance: 3-5 hours

  • Total duration: 8-12 hours

Safety aspects

Side effects

  • Increased body temperature

  • Tachycardia

  • Mydriasis

  • Possible gastrointestinal discomfort

Contraindications

  • Combination with MAO inhibitors

  • Cardiovascular diseases

  • Psychiatric history

Laboratory analysis

Pureté:  ≥97% (HPLC)
Stability:  Store in a cool, dry place (<25°C)
Impurities:  <0.5% (GC-MS analysis)

Statut juridique

Netherlands:  Opium Act Schedule I
Belgium:  Prohibited substance
EU:  Under EU NPS legislation

Research protocols

  1. Start low:  10mg initial test dose

  2. Pharmaceutical monitoring:  Blood pressure and temperature measurement

  3. Intervals:  Minimum 7 days between experiments

Important Warnings

❌ Pas de consommation humaine
❌ Do not combine with other psychoactives
❌ Avoid prolonged or frequent use

This product is intended solely for in vitro research et scientific study under controlled laboratory conditions.

Buvards artistiques 1cP-LSD 150 MCG Granulés O-DSMT 50 mg buvards 1V-LSD 150 MCG 6-CL-ADBA